Publication

The contemporary role of renal mass biopsy in the management of small renal tumors

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Amy Lim, University of UtahBrock O'Neil, Huntsman Cancer InstituteMarta Heilbrun, Emory UniversityChristopher Dechet, Huntsman Cancer InstituteWilliam T. Lowrance, Huntsman Cancer Institute
Language
  • English
Date
  • 2012-12-01
Publisher
  • Frontiers
Publication Version
Copyright Statement
  • © 2012 Lim, O'Neil, Heilbrun, Dechet and Lowrance.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 2 SEP
Start Page
  • 106
End Page
  • 106
Abstract
  • The selective use of percutaneous biopsy for diagnosis in renal masses is a relatively uncommon approach when compared to the management of other solid neoplasms. With recent advancements in imaging techniques and their widespread use, the incidental discovery of asymptomatic, small renal masses (SRM) is on the rise and a substantial percentage of these SRM are benign. Recent advances in diagnostics have significantly improved accuracy rates of renal mass biopsy (RMB), making it a potentially powerful tool in the management of SRM. In this review, we will discuss the current management of SRM, problems with the traditional view of RMB, improvements in the diagnostic power of RMB, cost-effectiveness of RMB, and risks associated with RMB. RMB may offer important information enabling treating clinicians to better risk-stratify patients and ultimately provide a more personalized treatment approach for SRM. © 2012 Lim, O'Neil, Heilbrun, Dechet and Lowrance.
Author Notes
  • William T. Lowrance, Division of Urology, Department of Surgery, Huntsman Cancer Institute, University of Utah, 1950 Circle of Hope, Suite 6405, Salt Lake City, UT 84112, USA. e-mail: will.lowrance@hci.utah.edu
Keywords
Research Categories
  • Health Sciences, Oncology
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items